Gen-Probe, Bayer call truce on patent row
This article was originally published in Clinica
Executive Summary
San Diego, California-based nucleic acid testing specialist Gen-Probe and Bayer Healthcare are ending their four-year legal wrangle involving multiple patent litigation and contract arbitrations with a settlement that would see the German drugs giant fork out up to $31.7m to its one-time business partner.